WEBULL
WebtradeDownload

Merck (MRK) Pilots Blockchain Cocoa Tracking With A New Digital Passport Push

Simply Wall St · 1d ago
  • Merck (NYSE:MRK) is partnering with The Hashgraph Group and PwC Germany on a blockchain-based cocoa traceability and digital product passport pilot.
  • The project applies Merck’s M-Trust physical authentication technology to cocoa supply chains in the food and agriculture sector.
  • The pilot is designed to support transparency, sustainability reporting, and regulatory compliance requirements such as deforestation due diligence and digital product passports.

For investors tracking how supply chain traceability and resource security intersect, the broader materials trend is also worth a closer look through 9 top copper producer stocks.

NYSE:MRK Earnings & Revenue Growth as at Sep 2026
NYSE:MRK Earnings & Revenue Growth as at Sep 2026

Merck is a global healthcare group with a market value of about $370.9b. This cocoa traceability pilot shows how a large pharmaceuticals player is testing its laboratory grade authentication tools in a heavily scrutinised food supply chain.

Beyond the headline: 5 risks and 2 things going right for Merck that every investor should see.

How does this cocoa pilot fit Merck’s broader strategy?

The cocoa traceability project gives Merck a way to apply its M-Trust authentication tools outside core biopharma, into food and agriculture supply chains. That lines up with the Narrative focus on turning a much larger pipeline and technology base into multiple growth drivers across different regulated industries, not just oncology.

Does this change the Merck Narrative investors have been using?

This pilot leans into a key Narrative catalyst, Merck’s push to turn R&D and acquired capabilities into more than 20 growth drivers with significant commercial potential. Extending M-Trust and digital product passports into sectors like food, luxury goods and electronics shows how the firm is testing new use cases that could help offset longer term risks such as KEYTRUDA’s loss of exclusivity.

If we take a look at the community Narrative for Merck, we can see how this news fits into the bigger investment story.

For Merck, what should investors watch next from this project?

The next useful marker is whether the cocoa pilot converts into paid rollouts or expanded trials with additional brands and categories over the next 12 to 18 months, especially in Europe where EUDR and ESPR rules apply first. Concrete adoption metrics such as number of product SKUs or suppliers brought onto TrackTrace with M-Trust integration will show how commercially scalable the concept is.

For the full picture including more risks and rewards, check out the complete Merck analysis.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.